0000899243-21-009513.txt : 20210303 0000899243-21-009513.hdr.sgml : 20210303 20210303185708 ACCESSION NUMBER: 0000899243-21-009513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210302 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guyer Shelly D CENTRAL INDEX KEY: 0001588984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 21711435 MAIL ADDRESS: STREET 1: 1025 GREEN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-02 0 0001501134 Invitae Corp NVTA 0001588984 Guyer Shelly D C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Financial Officer Common Stock 2021-03-02 4 S 0 1600 42.502 D 222920 D Common Stock 2021-03-02 4 S 0 1100 43.3382 D 221820 D Common Stock 2021-03-02 4 S 0 300 44.1667 D 221520 D The sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 8, 2020. Represents a weighted average sale price. Actual sale prices ranged from $42.02 to $43.01 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Includes an aggregate of 161,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Represents a weighted average sale price. Actual sale prices ranged from $43.03 to $44.00 per share. Represents a weighted average sale price. Actual sale prices ranged from $44.05 to $44.36 per share. /s/ Thomas Brida, Attorney-in-fact 2021-03-03